CEO Tried AI in Drug Testing–Here’s Why It Failed

CEO Tried AI in Drug Testing–Here’s Why It Failed
Dinkar Sindhu Courtesy of Bay Area Innovators
Steve Ispas
Steve Ispas
Reporter
|Updated:
In today’s episode, Dinkar Sindhu, CEO of Axis Clinicals, dives into the world of clinical research and the cautious integration of AI in drug development.